Quality control of next-generation sequencing-based HIV-1 drug resistance data in clinical laboratory information systems framework

Rupert Capina, Katherine Li, Levon Kearney, Anne Mieke Vandamme, P. Richard Harrigan, Kristel Van Laethem

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)
1 Downloads (Pure)

Abstract

Next-generation sequencing (NGS) in HIV drug resistance (HIVDR) testing has the potential to improve both clinical and public health settings, however it challenges the normal operations of quality management systems to be more flexible due to its complexity, massive data generation, and rapidly evolving protocols. While guidelines for quality management inNGSdata have previously been outlined, little guidance has been implemented for NGS-based HIVDR testing. This document summarizes quality control procedures for NGS-based HIVDR testing laboratories using a laboratory information systems (LIS) framework. Here, we focus in particular on the quality control measures applied on the final sequencing product aligned with the recommendations from theWorld Health Organization HIV Drug Resistance Laboratory Network.

Original languageEnglish
Article number645
JournalViruses
Volume12
Issue number6
DOIs
Publication statusPublished - Jun 2020

Keywords

  • HIV-1 drug resistance
  • Laboratory information systems
  • Next-generation sequencing
  • Quality control
  • Quality management

Cite this